Quarterly report pursuant to Section 13 or 15(d)

Note 1 - Nature of Business (Details Textual)

v3.21.2
Note 1 - Nature of Business (Details Textual)
Jun. 30, 2021
Number of Core Drug Technologies 3
Number of Drug Candidates 6
Number Of Drugs In Clinical Trials 5
Animal Life Sciences, Inc [Member]  
Equity Method Investment, Ownership Percentage 10.00%